https://www.selleckchem.com/pr....oducts/itacnosertib.
322, = 0.000, respectively). Furthermore, intraoperative blood loss was less ( = -2.199, = 0.029) and hospital costs were lower ( = -6.685, = 0.00. However, there was no significant difference in postoperative complications between the 2 groups ( 0.05). In patients who meet the screening criteria, PDC without ENBD after LCBDE is safe and effective and worthy of clinical application. In patients who meet the screening criteria, PDC without ENBD after LCBDE is safe and effective and worthy of clinical application. Surveillance
Like
Comment
Share
